Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment of Adults With…
− LIVTENCITY Is the First and Only Treatment Approved for This Indication by the EC1
− CMV Is One of the Most Common and Serious Post-transplant Infections and Can Lead to Loss of Transplanted Organ and Failure of Graft 2,3
OSAKA,…